Menu
GeneBe

rs10027479

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152618.3(BBS12):c.1381A>C(p.Asn461His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00423 in 1,614,222 control chromosomes in the GnomAD database, including 255 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N461S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.023 ( 136 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 119 hom. )

Consequence

BBS12
NM_152618.3 missense

Scores

7
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 2.57
Variant links:
Genes affected
BBS12 (HGNC:26648): (Bardet-Biedl syndrome 12) The protein encoded by this gene is part of a complex that is involved in membrane trafficking. The encoded protein is a molecular chaperone that aids in protein folding upon ATP hydrolysis. This protein also plays a role in adipocyte differentiation. Defects in this gene are a cause of Bardet-Biedl syndrome type 12. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023567379).
BP6
Variant 4-122743273-A-C is Benign according to our data. Variant chr4-122743273-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 100564.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-122743273-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0784 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BBS12NM_152618.3 linkuse as main transcriptc.1381A>C p.Asn461His missense_variant 2/2 ENST00000314218.8
BBS12NM_001178007.2 linkuse as main transcriptc.1381A>C p.Asn461His missense_variant 3/3
BBS12XM_011531680.3 linkuse as main transcriptc.1381A>C p.Asn461His missense_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BBS12ENST00000314218.8 linkuse as main transcriptc.1381A>C p.Asn461His missense_variant 2/21 NM_152618.3 P1
BBS12ENST00000542236.5 linkuse as main transcriptc.1381A>C p.Asn461His missense_variant 3/32 P1

Frequencies

GnomAD3 genomes
AF:
0.0232
AC:
3528
AN:
152218
Hom.:
135
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0807
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00778
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.0201
GnomAD3 exomes
AF:
0.00591
AC:
1487
AN:
251466
Hom.:
58
AF XY:
0.00435
AC XY:
591
AN XY:
135906
show subpopulations
Gnomad AFR exome
AF:
0.0826
Gnomad AMR exome
AF:
0.00318
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00225
AC:
3288
AN:
1461886
Hom.:
119
Cov.:
64
AF XY:
0.00198
AC XY:
1438
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.0809
Gnomad4 AMR exome
AF:
0.00376
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000174
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000106
Gnomad4 OTH exome
AF:
0.00447
GnomAD4 genome
AF:
0.0232
AC:
3537
AN:
152336
Hom.:
136
Cov.:
33
AF XY:
0.0228
AC XY:
1697
AN XY:
74508
show subpopulations
Gnomad4 AFR
AF:
0.0807
Gnomad4 AMR
AF:
0.00777
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000279
Gnomad4 OTH
AF:
0.0199
Alfa
AF:
0.00368
Hom.:
33
Bravo
AF:
0.0263
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0837
AC:
369
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00773
AC:
938
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 05, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 10, 2021- -
not provided Benign:2Other:1
not provided, no classification providedliterature onlyNEI Ophthalmic Genomics Laboratory, National Institutes of Health-- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 05, 2021This variant is associated with the following publications: (PMID: 20498079, 22025579, 27884173, 27894351) -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsMay 30, 2017- -
Bardet-Biedl syndrome 1 Benign:2
Benign, criteria provided, single submitterclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical CenterSep 21, 2015- -
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtDec 15, 2014- -
Bardet-Biedl syndrome 12 Benign:2
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Bardet-Biedl syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.42
Cadd
Benign
20
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.66
D;D
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.27
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.69
T;.
MetaRNN
Benign
0.0024
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Uncertain
2.6
M;M
MutationTaster
Benign
0.88
N;N
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.4
N;N
REVEL
Benign
0.15
Sift
Uncertain
0.0060
D;D
Sift4G
Uncertain
0.017
D;D
Polyphen
0.25
B;B
Vest4
0.30
MVP
0.70
MPC
0.44
ClinPred
0.045
T
GERP RS
0.49
Varity_R
0.14
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10027479; hg19: chr4-123664428; COSMIC: COSV58562513; COSMIC: COSV58562513; API